Filter results

Pharmaceutical Reports

By Geography
By Sector
By Publication Type
Benefit from discounts when you add multiple products to your basket
2 Products SAVE 10%
3 Products SAVE 15%
4 Products SAVE 20%
5 Products SAVE 25%
6 Products SAVE 30%
7 - 20 Products SAVE 35%
21 Products or more SAVE 40%
Showing
1-20 of 205
Advances in the Biosimilars and Injectable Generics Market 2016

Advances in the Biosimilars and Injectable Generics Market 2016

The injectable generics sector has been through a sustained period of consolidation over the last few years as the leading companies have increased their presence through acquisition. With this in mind, the increased level of ...
$995.00
Read More
Costa Rica Pharmaceuticals & Healthcare Report

Costa Rica Pharmaceuticals & Healthcare Report

BMI View: The approved loan from the World Bank will help improve the institutional management and organisation of healthcare delivery in Costa Rica's public healthcare sector, as well as enhance the financial sustainability of ...
$1,295.00
Read More
El Salvador Pharmaceuticals & Healthcare Report

El Salvador Pharmaceuticals & Healthcare Report

BMI View: El Salvador's slowly improving regulatory regime will continue to open up the local drug market to international players. The local government's commitment to healthcare will further improve the national healthcare system ...
$1,295.00
Read More
Guatemala Pharmaceuticals & Healthcare Report

Guatemala Pharmaceuticals & Healthcare Report

BMI View: Due to its small market size and low per capita pharmaceutical spending, the Guatemalan pharmaceutical market will continue to attract limited multinational drugmaker investment in 2016. Generic drugmakers in Latin America will continue to ...
$1,295.00
Read More
Honduras Pharmaceuticals & Healthcare Report

Honduras Pharmaceuticals & Healthcare Report

BMI View: Inequity and low coverage will continue to characterise the healthcare sector in Honduras. The local government will continue to support the primary healthcare network and promote the decentralisation of the healthcare sector. In 2016, ...
$1,295.00
Read More
Nicaragua Pharmaceuticals & Healthcare Report

Nicaragua Pharmaceuticals & Healthcare Report

BMI View: Access to affordable medicine will continue to be challenging for the majority of Nicaraguans in the coming years. Limited healthcare funding, low per capita pharmaceutical expenditure, a small and unregulated drug market and ...
$1,295.00
Read More
Panama Pharmaceuticals & Healthcare Report

Panama Pharmaceuticals & Healthcare Report

BMI View: Panama's decision to move forward with the unification of its public healthcare system will have a significant positive impact on the improvement of medical services in the country over the long term. ...
$1,295.00
Read More
Pharmaceuticals & Healthcare Q116 Round-Up

Pharmaceuticals & Healthcare Q116 Round-Up

The Pharmaceuticals & Healthcare Q116 Round-Up features BMI Research's forecasts for drugs and healthcare expenditure and imports and exports, focusing on the growth outlook for the prescription, OTC, patented drugs and generics market segments. BMI's Pharmaceuticals & ...
$580.00
Read More
Pharmaceuticals & Healthcare Q415 Round-Up

Pharmaceuticals & Healthcare Q415 Round-Up

The global pharmaceutical market is set to post a compound annual growth rate of 2.6% over the next five years. Combined sales of prescription drugs and over-the-counter medicines increased from USD1,043bn in 2013 to USD1,080bn ...
$580.00
Read More
The Year Ahead: Pharmaceuticals & Healthcare in 2016

The Year Ahead: Pharmaceuticals & Healthcare in 2016

The special report draws upon BMI’s expertise to provide detailed analysis of the risks and rewards companies will face in 2016, in established markets and emerging markets. The report will be especially relevant for ...
$995.00
Read More
Towards 2050: Megatrends In Industry, Politics And The Global Economy

Towards 2050: Megatrends In Industry, Politics And The Global Economy

Globalisation, Demographic Shifts, Urbanisation, Climate Change, and Internet Proliferation are the macroeconomic megatrends that will shape the 21st century. They are global, seemingly irreversible forces that have already made an incredible mark on economies and ...
$795.00
Read More
World Generic Market Report 2015 - Volume II: National Markets

World Generic Market Report 2015 - Volume II: National Markets

Global generic drug markets are increasingly subject to external and industry-specific risk factors. As part of the economic recovery, cost containment in healthcare has targeted spending on generic drugs, while generic manufacturers and their investors ...
$995.00
Read More
Algeria Pharmaceuticals & Healthcare Report

Algeria Pharmaceuticals & Healthcare Report

BMI View: The Algerian pharmaceutical market will remain attractive to multinational drugmakers , despite the slow pace of improvements in the regulatory and market access environment. Key market drivers such as growing demand for healthcare , rising ...
$1,295.00
Read More
Angola Pharmaceuticals & Healthcare Report

Angola Pharmaceuticals & Healthcare Report

BMI View: Like other oil-dependent countries , Angola has suffered from the large fall in the price of oil. The healthcare sector has been impacted by large budget cuts as a result of the lower government ...
$1,295.00
Read More
Argentina Pharmaceuticals & Healthcare Report

Argentina Pharmaceuticals & Healthcare Report

BMI View: In the near term, the substandard regulatory and market access environment will continue to tarnish Argentina's appeal to drugmakers. However, in the long term, Argentina stands among the most promising pharmaceutical markets ...
$1,295.00
Read More
Australia Pharmaceuticals & Healthcare Report

Australia Pharmaceuticals & Healthcare Report

BMI View: Drugmakers operating in Australia will face an increasingly challenging business environment as the Sixth Pharmacy Community Agreement's measures come into effect. This includes a 5% price cut to medicines listed on the F1 ...
$1,295.00
Read More
Bahrain Pharmaceuticals & Healthcare Report

Bahrain Pharmaceuticals & Healthcare Report

BMI View: Bahrain's p harmaceutical market will experience slight growth in 2016 as a result of medicine price cuts implemented in late 2015. The country's rising prevalence of lifestyle-related diseases and the uptake of compulsory ...
$1,295.00
Read More
Bangladesh Pharmaceuticals & Healthcare Report

Bangladesh Pharmaceuticals & Healthcare Report

BMI View: Replicating India's success in the generic drugs sector will remain a challenge for Bangladesh. The country's strategy of leveraging upon an extension of the patent waiver for least developed countries presents ...
$1,295.00
Read More
Belarus Pharmaceuticals & Healthcare Report

Belarus Pharmaceuticals & Healthcare Report

BMI View: Belarus poses challenges for multinational drugmakers given government initiatives to reduce the reliance on medicinal imports . The weak ruble has seen prices of foreign medicines rise to unaffordable levels and has led to ...
$1,295.00
Read More
Belgium Pharmaceuticals & Healthcare Report

Belgium Pharmaceuticals & Healthcare Report

BMI View : Belgium offers a stable pharmaceutical market with high per capita spe nding on medicines. However, drugmakers will increasingly find the government less willing to reimburse expensive, innovative medicines as it struggles to hit ...
$1,295.00
Read More
Showing
1-20 of 205